Decreased, Deformed, Defective-How HIV-1 Vpu Targets Peroxisomes.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
26 05 2020
Historique:
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 22 7 2020
Statut: epublish

Résumé

Peroxisomes are found in essentially all eukaryotic cells and have been described as important hubs in innate sensing and the induction of type III interferons upon viral infection. Nevertheless, it remains poorly investigated how viral pathogens modulate biogenesis or function of peroxisomes to evade innate sensing and restriction. In a recent study, Hobman and colleagues found that the accessory viral protein u (Vpu) of HIV-1 inhibits peroxisome activity by depleting cellular peroxisome pools. This depletion could be ascribed to a Vpu-dependent induction of four microRNAs (miRNAs) that suppress the expression of peroxisomal biogenesis factors PEX2, PEX7, PEX11B, and PEX13. Although the downstream effects on antiretroviral gene expression and HIV-1 replication remain to be determined, these findings provide important insights into peroxisome biogenesis and the modulation of cell organelles by HIV-1 Vpu.

Identifiants

pubmed: 32457250
pii: mBio.00967-20
doi: 10.1128/mBio.00967-20
pmc: PMC7251213
pii:
doi:

Substances chimiques

Human Immunodeficiency Virus Proteins 0
Viral Regulatory and Accessory Proteins 0
vpu protein, Human immunodeficiency virus 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2020 Hopfensperger and Sauter.

Références

PLoS Pathog. 2017 Jun 8;13(6):e1006360
pubmed: 28594894
J Biol Chem. 2004 Jan 2;279(1):788-95
pubmed: 14561767
Nat Immunol. 2014 Aug;15(8):717-26
pubmed: 24952503
Cell. 2010 May 14;141(4):668-81
pubmed: 20451243
Mol Cell Proteomics. 2018 Nov;17(11):2242-2255
pubmed: 30037810
PLoS Pathog. 2015 Nov 20;11(11):e1005264
pubmed: 26588843
Trends Microbiol. 2019 Nov;27(11):906-914
pubmed: 31331665
J Virol. 2015 Dec;89(24):12349-61
pubmed: 26423946
Exp Biol Med (Maywood). 2017 Apr;242(8):850-858
pubmed: 28346011
J Gen Virol. 2017 Dec;98(12):3086-3092
pubmed: 29058646
mBio. 2020 Mar 3;11(2):
pubmed: 32127461

Auteurs

Kristina Hopfensperger (K)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Daniel Sauter (D)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany daniel.sauter@uni-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH